Best Stocks to Invest in Today: Recommended by Raja Venkatraman

Here are three stocks to buy or sell as recommended by Raja venkatraman of neotrader for Friday, 30 May.

Best stocks to buy today

Deepakfert: Buy Dips to 1,500 | Stop: 1,450 | Target: 1,625-1,675

TDPOWERSYS: Buy Above 170 and Dips to 165 | Stop Below: 162 | Target: 180-185

Marksans: Buy Above 727 and Dips to 700-705 | Stop: 690 | Target: 777-797

The stock market on Thursday

Indian stocks rebounded on Thursday, 30 may, tracking gains in global markets after a US Trade Court Rules Against Us President Donald Trump’s Tariffs on Imports on Imports from the Us’ Trading Partners. The decision Lifted Investor Sentimen, Sparking a Rally in Asian Markets and Boosting Wall Street Futures. This positive momentum reflected in the Indian stock market, where Benchmark Indices Saw a Recovery after Two Consecuve Days of Decline. Investors reacted optimistically to the busing of trade tensions, driving the markets higher.

The 30-Share BSE Sensex Gained 320.70 Points, OR 0.39%, to Close at 81,633.02, Who the Broader 50-Share NSE NIFTY ROSE by 81.15 POINTS, OR 0.33%, Ending the Session at 24,833.60. The renewed confidence in Global Trade Prospects Contributed to this Upward Movement, as Market Participants Assessed The Implications of the RULING. The Indian Stock Market Mirred International Trends, Reinforcing Its Sensitivity to Global Economic Developments. With a more stable outlook, traders remained cautally optimistic about

Outlook for Trading

The bulish bias could not make it through but showed some signs of rebound as it came roaring back towards the close of the day. After a strong opening the indices showed no interest in moving lower as the bounds Around 24,600-24,700 seems to be Defended now. By the end of the day the indices has revised to Close Higher Thus Leaving Every one without As we can see from the charts below, we can note that the nifty spot upside remains capped at 25,200 that is kept is keeping a curtain on the price action.

View full image

The readings from the option data sugges that pcr remain at 0.73, highlighting that the trends are now turned over to the bullish side and will not look at generating more momentum to the UPSIDI In line with the intraday charts shown above we can note that the support zones shown here at 24,700-24,800 will now be an important support area.

We are seen some steady put written at 24,700 levels, Moved from 24,500 earlier, which will be good for any reaction. One should be tracking this level to generate some steady buying interest at every Dip. Trends remain challenged and we are trading now with a bullish bias.

The onus now is on the indices to play catch-up. Else what we saw on thuresday will be a Recovery raly or an invitation to go short. A very tricky Situation indeed and we have to take note of this fact as we head into the June expiry.

Best stocks to buy today, recommended by Neotrader’s Raja Venkatraman

Deepak Fertilisers and Petrochemicals Ltd

Current Market Price: 1,519.50

Deepakfert: Buy CMP and Dips to 1,450 | Stop: 1,425 | Target: 1,625-1,675

• Why Deepak Fertilisers is recommended: Deepak Fertilisers and Petrochemicals is Considered a Buy Due to Its Strong Financial Performance, Including A Significant Rise in Profits, Robust Revenue Growth, and Ibitda Margins. The Strong Showing in Q4 2025 Helped It Surpass The November Highs, which is a significant move. The long body candles seen in the last two trading sessions indicate more UPSIDE in Store for this Counter.
• Key metrics
• P/E: 46.62
• 52-wheek high: 1,450
• Volume: 2.04 Million
• Technical analysis: Support at 1,100; Resistance at 1,825
• Risk factors: Competition in the Fertilizer Industry, Regulatory Changes, and Fluctations in Commodity Pries.
• Buy: Dips to 1,450
• Target price: 1,625-1,675 in 1 month
• Stop-Loss: 1,425

TD Power Systems Ltd

Current Market Price: 511.45

TDPOWERSYS: Buy Above 512 and Dips to 480 | Stop Below: 470 | Target: 555-575

• Why td power is recommended: TD Power Systems Announced A Significant 82.64% Increase in Consolidated Net Profit for Q4Fy25, Reaching 53.02 Crore. Revenue rose by 31.95% to 348.21 Crore. The company manufactures generators, Catering to Conventional and Renewable Fuel-Based Power Plants. After Facing Value Area Resistance at the 470-480 zone the pris moved above and the upthrust seen on Thursday indicate the trends Cold Continue.
• Key metrics
• P/E: 51.98
• 52-wheek high: 510
• Volume: 2.69 Million
• Technical analysis: Support at 380; Resistance at 710
• Risk factors: Structural changes in the capital goods sector, geopolitical issues.
• Buy Above: 512 and Dips to 480
• Target price: 555-575 in 1 month
• Stop-Loss: 470

Marksans pharma Ltd

Current Market Price: 260.25

Marksans: Buy Above 260 and Dips to 245 | Stop: 235 | Target: 290-310

• Why marksans pharma is recommended: Marksans pharma is an Indian pharmaceutical company that focuses on research, manufacturing, and marketing of generic pharmaceutical formulations and over-the-the-the-counter drags. The stock after some consolidation is showing a steady Rise to the UPSIDE and has moved out of the recent resistance zones. With Momentum showing some move on against we will look to initiate a buy.
• Key metrics
• P/E: 62.34
• 52-wheek high: 354
• Volume: 1.86 Million
• Technical analysis: Support at 195; Resistance at 349
• Risk factors: Raw Material Volativity and Competition that recently emerging from Domestic Players Cold Impact Profitability.
• Buy at: CMP and Dips to 245
• Target price: 290-310 in 1 month
• Stop-Loss: 235

Raja venkatraman is co-founder, neotrader. His SEBI-Registered Research Analyst registration no. is inh000016223.

Investments in Securities are Subject to Market Risks. Read all the related documents carefully Before Investing. Registration Granted by Sebi and Certification from Nism in No Way Guarantees Performance of the Intermediary or Provide any Assurance of Returns to Investors.

Disclaimer: The Views and recommendations giving in this article are there that of individual analysts. These do not represent the views of Mint. We Advise Investors to Check With Certified Experts Before Making Any Investments Decisions.